Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer
- 1 April 2004
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 44 (1) , 79-88
- https://doi.org/10.1016/j.lungcan.2003.09.015
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinomaCancer, 2001
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Dose escalation for non-small cell lung cancer using conformal radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1997
- High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: Unusual toxicity and promising early resultsInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Accelerated repopulation during radiotherapy: Quantitative evidence for delayed onsetRadiation Oncology Investigations, 1993
- Loss of local control with prolongation in radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Astro plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Effect of postoperative radiotherapy on changes in pulmonary function in patients with stage II and IIIA lung carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method geraldInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Complication Probability as Assessed from Dose-Volume HistogramsRadiation Research, 1985